ArticleFrontiers in oncology2026

Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.

Francesco Fedeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.